Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Neurologic Clinics|February 1, 1990
Pharmacokinetic and pharmacodynamic considerations in management of motor response fluctuations in Parkinson's diseaseJ M CedarbaumClinical Pharmacokinetics|September 1, 1987
Clinical pharmacokinetics of anti-parkinsonian drugsJ M CedarbaumAmyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|July 24, 2001
Disease status and use of ventilatory support by ALS patients. BDNF Study GroupJ M Cedarbaum, N StamblerJournal of the Neurological Sciences|January 7, 1998
Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trialsJ M Cedarbaum, N StamblerNeurochemical Pathology|February 1, 1986
Mitochondrial dysfunction and spinocerebellar degenerationsJ M Cedarbaum, J P BlassThe Journal of Comparative Neurology|March 1, 1978
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing techniqueJ M Cedarbaum, G K AghajanianNeurology|October 1, 1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseJ M Cedarbaum, C W OlanowNeurology|June 1, 1990
Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirementsJ M Cedarbaum, M Silvestri, H KuttClinical Neuropharmacology|August 1, 1991
Reduction of circulating 3-O-methyldopa by inhibition of catechol-O-methyltransferase with OR-611 and OR-462 in cynomolgus monkeys: implications for the treatment of Parkinson's diseaseJ M Cedarbaum, G Leger, M GuttmanNeurology|January 27, 1998
Prognostic indicators of survival in ALS. ALS CNTF Treatment Study GroupN Stambler, M Charatan, J M CedarbaumPageof 5